Explore / Clinical trial
Clinical trial

Chart Review of Patients Undergoing Ketamine Treatments for Depression

Sunnybrook Health Sciences CentreCompletedStarted Apr 1, 2022250 enrolledCanadaNCT07099235

Abstract

The Ontario Ketamine and Infusion Centre (OKIC) is a CPSO-certified Level-II OHP and an outpatient centre for intravenous ketamine treatments for treatment-resistant depression. This retrospective, observational study aims to conduct a chart review on patients receiving ketamine in a naturalistic setting to develop our understanding of ketamine as an interventional approach for treatment-resistant depression.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Major Depressive DisorderRetrospectiveDepression - Major Depressive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.